GSK:BCBA
Glaxosmithkline CEDEAR
ARSÂ 20,060.00
arrow_upward
+0.65%(+130.00) 1D
Sep 28, 5:00:00 PM GMT-3 · ARS
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GSK...
Open
ARSÂ 19,930.00
High
ARSÂ 20,150.00
Low
ARSÂ 19,930.00
Mkt. cap
76.90B
Avg. vol.
0.00
Volume
109.00
52-wk high
ARSÂ 22,760.00
52-wk low
ARSÂ 14,960.00
Shares outstanding
4.05B
No. of employees
67K
Open
ARSÂ 19,930.00
High
ARSÂ 20,150.00
Low
ARSÂ 19,930.00
Mkt. cap
76.90B
Avg. vol.
0.00
Volume
109.00
52-wk high
ARSÂ 22,760.00
52-wk low
ARSÂ 14,960.00
Shares outstanding
4.05B
No. of employees
67K
News stories
From web sources and news partners
Traders Union
·
3 hours ago
GSK stock tests GBX1,939 resistance as intraday buyers stay in control
AD HOC NEWS
·
14 hours ago
GSK stock last trades at GBp 1,860.00 on September 28, 2026
Traders Union
·
1 day ago
Nuvalent acquisition supports GSK stock as it holds near GBX1,834 support
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About Glaxosmithkline CEDEAR
CEOEmma Walmsley | Emma Walmsley
Employees66.8K
FoundedDec 27, 2000
Headquarters-
SectorPharmaceutical industry
Websitegsk.com